MBM was founded in 2016 by industry veterans with deep expertise and networks in the pharmaceutical and biotech industry. MBM's vision is to create a dynamic platform to enable the translation and commercialization of precision medicine technologies and products in China and eventually the world. Our current focus is in the field of molecular diagnostics and medical AI technologies for cancer patient diagnosis and prognosis. We are actively seeking partnerships with research institutes and companies who are looking to establish commercial partnerships in China and overseas.